Watch, get inspired, and subscribe to stay informed.
The first in the series, "Burzynski, the Movie," is an internationally award-winning documentary originally released in 2010 (with an Extended Edition released in 2011) that tells the true story of a medical doctor and Ph.D biochemist named Dr. Stanislaw Burzynski who won the largest, and possibly the most convoluted and intriguing legal battle against the Food & Drug Administration in American history.
His victorious battles with the United States government were centered around Dr. Burzynski's gene-targeted cancer medicines he discovered in the 1970's called Antineoplastons, which have currently completed Phase II FDA-supervised clinical trials in 2009 and has been given permission by the FDA to begin the final phase of FDA testing–randomized controlled clinical trials. .
When Antineoplastons are approved, it will mark the first time in history a single scientist, not a pharmaceutical company, will hold the exclusive patent and distribution rights on a paradigm-shifting medical breakthrough.Read the complete synopsis
In the compelling follow-up to the first internationally award-winning documentary, “Burzynski: Cancer is Serious Business, Part II” explores the current status of Antineoplastons' clinical testing sanctioned by the United States Food & Drug Administration—and features a modern story of the struggling journeys of cancer patients being treated today at the Burzynski Clinic in Houston, Texas.
For most patients undergoing Burzynski's treatment, their advanced cancer itself runs secondary to the constant barrage of skepticism coming not only from their local oncologists, but also from friends and family who feel their loved ones are making suspect treatment decisions—even though mainstream oncology has already left many for dead.
As the story unfolds, it reveals a real-time change of hearts and minds from many of these doctors and families and with candid interviews with board-certified oncologists, surgeons and neurosurgeons.Read the complete synopsis